The Cancer Drug Fraction of Metabolism Database
- PMID: 31206254
- PMCID: PMC6656935
- DOI: 10.1002/psp4.12417
The Cancer Drug Fraction of Metabolism Database
Abstract
This study aims to create a database for quantifying the fraction of metabolism of cytochrome P450 isozymes for cancer drugs approved by the US Food and Drug Administration. A reproducible data collection protocol was developed to extract essential information, including both substrate-depletion and metabolite-formation data from publicly available in vitro selective cytochrome P450 enzyme inhibition studies. We estimated the fraction of metabolism from the curated data. To demonstrate the utility of this database, we conducted an in vitro drug interaction prediction for the 42 cancer drugs. In the drug-drug interaction prediction, we identified 31 drug pairs with at least one cancer drug in each pair that had predicted area under concentration ratios > 2. We further found clinical drug interaction pieces of evidence in the literature to support 20 of these 31 drug-drug interaction pairs.
© 2019 The Authors CPT: Pharmacometrics & Systems Pharmacology published by Wiley Periodicals, Inc. on behalf of the American Society for Clinical Pharmacology and Therapeutics.
Conflict of interest statement
The authors declared no competing interests for this work. As an Associate Editor for
Figures


References
-
- Rowland, M. & Tozer, T.N. Clinical Pharmacokinetics/Pharmacodynamics. 4th edn (Lippincott Williams and Wilkins, Philadelphia, PA, 2005).
-
- Shen, D.D. , Kunze, K.L. & Thummel, K.E. Enzyme‐catalyzed processes of first‐pass hepatic and intestinal drug extraction. Adv. Drug Deliv. Rev. 27, 99–127 (1997). - PubMed
-
- Renwick, A. The metabolism of antihistamines and drug interactions: the role of cytochrome P450 enzymes. Clin. Exp. Allergy 29, 116–124 (1999). - PubMed
-
- Ereshefsky, L. Drug‐drug interactions involving antidepressants: focus on venlafaxine. J. Clin. Psychophrmacol. 16, 37S–50S (1996). - PubMed
-
- Eichelbaum, M. , Ingelman‐Sundberg, M. & Evans, W.E. Pharmacogenomics and individualized drug therapy. Annu. Rev. Med. 57, 119–137 (2006). - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources